APA (7th ed.) Citation

Delgado‐Arija, M., Dolores García‐Cosío Carmena, M., Martínez‐Sellés, M., Guerra, J. M., Valdivielso, S., González‐Juanatey, J. R., . . . Martínez‐Dolz, L. (2025). Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2‐trans,4‐cisdecadienoylcarnitine levels. Clinical & Translational Medicine, 15(9), 1. https://doi.org/10.1002/ctm2.70398

Chicago Style (17th ed.) Citation

Delgado‐Arija, Marta, et al. "Plasma Metabolites in Patients of the REDINSCOR III Registry Hospitalised for De Novo Heart Failure with Preserved Ejection Fraction: Prognostic Implications of Linoleamide and 2‐trans,4‐cisdecadienoylcarnitine Levels." Clinical & Translational Medicine 15, no. 9 (2025): 1. https://doi.org/10.1002/ctm2.70398.

MLA (9th ed.) Citation

Delgado‐Arija, Marta, et al. "Plasma Metabolites in Patients of the REDINSCOR III Registry Hospitalised for De Novo Heart Failure with Preserved Ejection Fraction: Prognostic Implications of Linoleamide and 2‐trans,4‐cisdecadienoylcarnitine Levels." Clinical & Translational Medicine, vol. 15, no. 9, 2025, p. 1, https://doi.org/10.1002/ctm2.70398.